3Sunasseek,vile R. Tumor angiogenesis: Hitting cancer where it hurts[J]. Current Biology, 1997,7 (2): 282-285.
4O'Reilly MS,Boehm T,Shing Y,et al. Endostatin:an endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997,88(2) : 277.
5Beohm T, Folkman J, Brmoder T,et al. Antigiogenis therapy of experimental cancer does not induce acquired drug resistance[J].Naterl , 1997,390(2) :404.
6Rckwell P,O'Connor WJ,King K,et al. Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factorreceptors by phosphorothioute oligodeoxynucleotides[J]. Proc, Natl Acad Sci USA, 1997,94 (32): 6523.
7O'Reilly MS, Boehm T. Shing Y,et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth[J]. Cell, 1997,88(2): 277-288.
8Deane BR,antos PL. The vasculature of experimental brain tumors. 1＞A sepuential liaght and electron microscope study of angioensis[J]. J Neurol Sci,1981,49(1) :55.
9Folkman J. What is the evidence that tumors are angiogenesis dependent?[J]. J Natl Cancer Inst, 1990, 82( 1 ) :4-6.
10O'Reilly MS, Bohem T, Shing Y, et al. Endostating: an endogenous inhibitor of angiogenesis and rumor growth[J]. Cell, 1997,88(2) :277-285.
